Movement Alert｜PHARMARON Falls 5.46% in Regular Trading, CXO Selloff Resumes as Sector Pressure Returns

Market Focus10-22 13:02

On October 22, PHARMARON fell 5.46% in Regular Trading, trading at HK$26.02, with turnover of HK$111 million.

The move came as the Life Sciences Tools & Services sector weakened broadly. Recent market coverage indicated that CXO names including WUXI BIO, WUXI XDC and WUXI APPTEC were also under pressure, while PHARMARON was described as falling with the sector after a short-lived rebound tied to easing concerns over its completed 1.00% block transfer.

Background context shows the company previously completed the transfer of 18.373 million A shares, or 1.00% of total share capital, at RMB38.89 per share for about RMB715 million, with the transferred shares locked up for six months. The company is also scheduled to review third-quarter results on October 27. Earlier relief from reduced overhang after the placement appears to have been overshadowed by renewed sector weakness.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment